Cerezyme
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
58468-4663 -
Package NDC
58468-4663-1 -
Application number
BLA020367 -
SPL ID
fc9b5df4-94e5-43b1-a827-dff85f7cf510 -
SPL set ID
df60f030-866b-4374-a31f-8ae3f6b45c38 -
UNII
Q6U6J48BWY -
RxCUI
1726266 -
RxCUI
1726268
What the source publishes
- Labeler
- Genzyme Corporation
- Active ingredients
- IMIGLUCERASE
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Routes
- INTRAVENOUS
- Administrative status
- present-in-source-snapshot
- Marketing status
- BLA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Cerezyme",
"splId": "fc9b5df4-94e5-43b1-a827-dff85f7cf510",
"labels": [
{
"setId": "df60f030-866b-4374-a31f-8ae3f6b45c38",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=df60f030-866b-4374-a31f-8ae3f6b45c38",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=df60f030-866b-4374-a31f-8ae3f6b45c38"
}
],
"routes": [
"INTRAVENOUS"
],
"labeler": "Genzyme Corporation",
"finished": true,
"packaging": [
{
"sample": false,
"description": "1 VIAL, GLASS in 1 CARTON (58468-4663-1) / 10 mL in 1 VIAL, GLASS",
"package_ndc": "58468-4663-1",
"identifierStatus": "well-formed",
"marketing_start_date": "19940523"
}
],
"productId": "58468-4663_fc9b5df4-94e5-43b1-a827-dff85f7cf510",
"useDomain": "unknown",
"dosageForm": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
"productNdc": "58468-4663",
"deaSchedule": null,
"genericName": "IMIGLUCERASE",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "IMIGLUCERASE",
"strength": "40 U/mL"
}
],
"applicationNumber": "BLA020367",
"marketingCategory": "BLA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "19940523",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"M0009360",
"N0000175820"
],
"unii": [
"Q6U6J48BWY"
],
"rxcui": [
"1726266",
"1726268"
],
"spl_set_id": [
"df60f030-866b-4374-a31f-8ae3f6b45c38"
],
"pharm_class_cs": [
"Glucosylceramidase [CS]"
],
"pharm_class_epc": [
"Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC]"
],
"manufacturer_name": [
"Genzyme Corporation"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:58468-4663_fc9b5df4-94e5-43b1-a827-dff85f7cf510"